blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0579412

EP0579412 - 1,2,4-trioxygenated benzene derivatives useful as a leukotriene antagonists [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.08.1999
Database last updated on 05.10.2024
Most recent event   Tooltip13.08.1999No opposition filed within time limitpublished on 29.09.1999 [1999/39]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [1994/03]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, Indiana 46285 / US
Inventor(s)01 / Sofia, Michael Joseph
20 Bennett Road
Carmel, Indiana 46032 / US
[1994/03]
Representative(s)Hudson, Christopher Mark, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor Windlesham
Surrey GU20 6PH / GB
[N/P]
Former [1995/32]Hudson, Christopher Mark, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor
Windlesham Surrey GU20 6PH / GB
Former [1994/03]Hudson, Christopher Mark
Lilly Industries Limited European Patent Operations Erl Wood Manor
Windlesham Surrey GU20 6PH / GB
Application number, filing date93305090.829.06.1993
[1994/03]
Priority number, dateUS1992090749201.07.1992         Original published format: US 907492
[1994/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0579412
Date:19.01.1994
Language:EN
[1994/03]
Type: B1 Patent specification 
No.:EP0579412
Date:07.10.1998
Language:EN
[1998/41]
Search report(s)(Supplementary) European search report - dispatched on:EP02.11.1993
ClassificationIPC:C07D311/66, C07D257/04, A61K31/35, A61K31/41
[1994/03]
CPC:
C07D257/04 (EP,US); A61P29/00 (EP); A61P37/08 (EP);
A61P43/00 (EP); C07D311/66 (EP,US)
Designated contracting statesDE,   ES,   FR,   GB,   IT [1998/25]
Former [1994/03]AT,  BE,  CH,  DE,  DK,  ES,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  NL,  PT,  SE 
TitleGerman:In Stellung 1,2,4 sauerstoffsubstituierte Benzene Derivate, nützlich als Leukotrien Antagonisten[1994/03]
English:1,2,4-trioxygenated benzene derivatives useful as a leukotriene antagonists[1994/03]
French:Benzene oxygenès aux positions 1,2 et 4 utiles comme antagonistes de leukotriens[1994/03]
Examination procedure05.07.1993Examination requested  [1994/03]
16.12.1996Despatch of a communication from the examining division (Time limit: M06)
14.04.1997Reply to a communication from the examining division
21.05.1997Despatch of a communication from the examining division (Time limit: M06)
19.11.1997Reply to a communication from the examining division
23.12.1997Despatch of communication of intention to grant (Approval: Yes)
11.03.1998Communication of intention to grant the patent
18.05.1998Fee for grant paid
18.05.1998Fee for publishing/printing paid
Opposition(s)08.07.1999No opposition filed within time limit [1999/39]
Fees paidRenewal fee
07.04.1995Renewal fee patent year 03
19.03.1996Renewal fee patent year 04
16.04.1997Renewal fee patent year 05
30.04.1998Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0132366  (LILLY CO ELI [US]) [A] 1,2,4-9 * claims 1,6-8 *;
 [A]EP0336068  (HOFFMANN LA ROCHE [CH]) [A] 1,2,4-9 * claims 1,9-13 *;
 [A]EP0150447  (SEARLE & CO [US]) [A] 1,2,4-9 *pages 4-6*;; claim 1 *;
 [A]EP0108592  (LILLY CO ELI [US]) [A] 1,2,4-9 * page 54, line 9 - page 56, line 22; claims 1,9,10 *
 [PX]  - MICHAEL J. SOFIA ET AL, "Ortho-alkoxyphenol leukotriene B4 receptor antagonists", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (1992), vol. 2, no. 12, pages 1669 - 1674 [PX] 1-9 * the whole document *
 [PX]  - MICHAEL J. SOFIA ET AL, "Ortho-alkoxyphenol leukotriene B4 receptor antagonists:effect of a chroman carboxylic acid", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (1992), vol. 2, no. 12, pages 1675 - 1680 [PX] 1-9 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.